BEIJING, Sept 24 (Reuters) - China's Sinovac Biotech expects to begin analysing final-stage human trial data on its coronavirus vaccine candidate this year to decide whether it is effective enough to ...
TAIPEI, Taiwan (AP) — China has given broader approval for the domestic-made Sinovac coronavirus vaccine, expanding those who can receive it beyond the high-risk and priority groups already allowed ...
Sinovac Biotech Ltd. (NASDAQ:SVA) (“Sinovac” or the “Company”), a leading provider of biopharmaceutical products in China, today announced that the China National Medical Products Administration (NMPA ...
THE HAGUE, Netherlands (AP) — The European Union’s drug regulator announced Tuesday that it has started a rolling review of China’s Sinovac coronavirus vaccine to assess its effectiveness and safety, ...
Many countries are betting on a vaccine from China to help them stop the coronavirus — although questions are surfacing about whether it's a smart bet. The vaccine is made by the Chinese ...
SANTIAGO (Reuters) – Chilean authorities said on Friday that China’s Sinovac had begun evaluating potential sites for the construction of a vaccine plant in Chile that could begin producing doses of ...
BEIJING--(BUSINESS WIRE)--Sinovac Biotech Ltd. (“SINOVAC” or the “Company”) (NASDAQ: SVA), a leading provider of biopharmaceutical products in China, today kicked off the enrollment for a Phase III ...
Sinovac Biotech Ltd. (NASDAQ: SVA) (“SINOVAC” or the “Company”), a leading provider of biopharmaceutical products in China, today announced that it has received a notification letter dated January 2, ...
JAKARTA (Reuters) - Indonesia gave Sinovac Biotech's COVID-19 vaccine its first emergency use approval outside China on Monday as the world's fourth most populous country launches nationwide ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results